Purpose

• Clarify how flavoring agents are treated under Minnesota’s drug-standards law. The bill trades a current overlap between compounding and flavoring by explicitly exempting flavoring agents from the definition of compounding, aiming to make it easier to improve the taste of medications without triggering compounding rules.

Main Provisions

• Amends Minnesota Statutes 2024 section 151.01, subdivision 35 (Compounding):
  • Restates what counts as compounding: preparing, mixing, assembling, packaging, and labeling a drug for an identified patient under a practitioner’s prescription, including anticipatory compounding and preparations using nonprescription substances, with several exceptions.
  • Keeps several conditions in place, such as compounding generally needing a prescription drug order, except where the chapter or board rules permit otherwise, and allows minor deviations driven by safety factors (radioactivity, volume, stability) under supervision of a licensed nuclear pharmacist or physician.
  • Excludes flavoring agents from being considered compounding.
• Adds Minnesota Statutes 2024, section 151.01, subdivision 44 (Flavoring agent):
  • Defines flavoring agent as a therapeutically inert, nonallergenic substance of inactive ingredients added to a drug to improve taste and palatability.

Significant Changes to Existing Law

• Flavoring agents are no longer part of the compounding definition. This formal exemption clarifies that adding flavors to a drug does not constitute compounding, reducing regulatory friction for making medications easier to swallow or take, particularly for populations that struggle with taste.

Practical Impact

• Pharmacists and prescribers can add flavoring agents to medications without the added regulatory steps tied to compounding, provided the agents meet the definition of therapeutically inert and nonallergenic.
• The existing compounding framework (which generally requires a prescription, allows anticipatory compounding, and includes safeguards around labeling and safety) remains in place for non-flavoring preparations.
• Flavoring cannot be used to bypass other safety or labeling requirements; the flavoring agent itself must be inert and nonallergenic.

Key Concepts to Understand

• Compounding
• Flavoring agent
• Prescription drug order
• Anticipatory compounding
• FDA labeling
• Nonprescription substances
• Therapeutically inert
• Nonallergenic
• Inactive ingredients
• Palatability and taste

---

Relevant Terms - compounding - flavoring agent - prescription drug order - anticipatory compounding - FDA labeling - inactive ingredients - therapeutically inert - nonallergenic - palatability - taste - nonprescription substances - minor deviation - radioactivity - stability - nuclear pharmacist - physician